Deals & Cases

10 von 554 Einträgen wurden gefunden.
2019-11-20

On November 13, 2019, UBS Group AG (the Issuer) successfully completed the issuance of CHF 275 m 3.00 per cent. Tier 1 Capital Notes (the Notes).

On November 13, 2019, UBS Group AG (the Issuer) successfully completed the issuance of CHF 275 m 3.00 per cent. Tier 1 Capital Notes (the Notes). The Notes are "high trigger" regulatory capital instruments that are eligible to fulfill UBS Group AG's Swiss going concern requirements.


The Notes are governed by Swiss law, and have been admitted to trading, and application has been made for a listing of the Notes, on the SIX Swiss Exchange.


Homburger advised UBS with respect to all regulatory and transactional aspects of Swiss law. The Homburger team included partners Benedikt Maurenbrecher, Stefan Kramer (both Banking and Finance | Capital Markets) and Stefan Oesterhelt (Tax), as well as counsel Lee Saladino and associate Olivier Baum (both Banking and Finance | Capital Markets).

Mehr lesen
2019-11-14

On November 13, 2019 and November 14, 2019, respectively, Amun AG (Amun), a Zug-based special purpose issuance vehicle of the fintech group Amun, successfully dual-listed several of its USD-denominated Exchange Traded Products (ETPs) on the BX Swiss.

On November 13, 2019 and November 14, 2019, respectively, Amun AG (Amun), a Zug-based special purpose issuance vehicle of the fintech group Amun, successfully dual-listed several of its USD-denominated Exchange Traded Products (ETPs) on the BX Swiss. These products (Tickers: ABTC, AETH, AXRP, ABCH, ABNB and AXTZ) are linked to the performance of Bitcoin (BTC), Ethereum (ETH), Ripple (XRP), Bitcoin Cash (BCH), Binance Coin (BNB) or Tezos (XTZ), as applicable. On BX Swiss, the USD-denominated products will be quoted in Swiss Francs (CHF) – specifically allowing Swiss retail investors to invest and trade in CHF. Each product is fully collateralized by the respective underlying, which is stored with an independent custodian (Kingdom Trust or Coinbase, as applicable). These ETPs are the first ETPs listed on BX Swiss' new Exchange Traded Products segment and the first dual-listed ETPs in Switzerland.


Homburger advised Amun with respect to all aspects of Swiss law. The Homburger team was led by partners Benjamin Leisinger (Capital Markets, Banking and Finance) and Daniel Haeberli (Capital Markets, Technology and Digital Economy) and comprised counsel Eduard De Zordi, associate Urs Meier and paralegal Ganna Goncharova (all Banking and Finance).

Mehr lesen
2019-11-14

On November 14, 2019, Amun AG (Amun), a Zug-based special purpose issuance vehicle of the fintech group Amun, successfully listed its new series of USD-denominated crypto-linked Exchange Traded Products (ETPs) on the SIX Swiss Exchange (Ticker: AXTZ) under its updated issuance program.

On November 14, 2019, Amun AG (Amun), a Zug-based special purpose issuance vehicle of the fintech group Amun, successfully listed its new series of USD-denominated crypto-linked Exchange Traded Products (ETPs) on the SIX Swiss Exchange (Ticker: AXTZ) under its updated issuance program. As of the same date, the AXTZ ETPs are dual-listed and quoted in CHF on the BX Swiss.


The underlying asset of this series is Tezos (XTZ). The underlying assets are held by or on behalf of Amun through an independent custodian and serve as a reference for the value of the ETPs. They collateralize the respective series on a 1:1 basis. The Tezos (XTZ) serving as collateral are purchased on the open market or in direct purchases from designated primary sources of liquidity, including reputable authorized exchanges.


Homburger advised Amun with respect to all aspects of Swiss law. The Homburger team was led by partner Benjamin Leisinger (Capital Markets) and comprised associate Urs Meier and paralegal Ganna Goncharova (both Banking and Finance).

Mehr lesen
2019-11-13

On October 4, 2019, Homburger's client entered into an agreement to acquire a large real estate portfolio in the Western part of Switzerland comprising 25 real properties located in three cantons through the acquisition of three companies owning the real estate portfolio.

On October 4, 2019, Homburger's client entered into an agreement to acquire a large real estate portfolio in the Western part of Switzerland comprising 25 real properties located in three cantons through the acquisition of three companies owning the real estate portfolio. The transaction was closed on October 17, 2019.


The Homburger team in this transaction was led by partner Daniel Hasler (Corporate | M&A) and included partner Peter Riedweg (Tax), associates Olivier Bühlmann, Karin Mattle, Sarah Chevalley and Christophe Chatelanat (all Corporate | M&A), Stefan Gäumann (Real Estate), David Borer (Banking and Finance), Laetitia Fracheboud (Tax) and junior associate Nicolas Eckert (Corporate | M&A).

Mehr lesen
2019-11-12

On November 4, 2019, IWG plc (LON: IWG) announced that it has agreed to sell Regus Holding GmbH, Zug, and its 38 flexible co-working locations in Switzerland, to a joint entity owned by private banking group J. Safra Group and real estate investor P. Peress Group.

On November 4, 2019, IWG plc (LON: IWG) announced that it has agreed to sell Regus Holding GmbH, Zug, and its 38 flexible co-working locations in Switzerland, to a joint entity owned by private banking group J. Safra Group and real estate investor P. Peress Group. The sale is expected to be closed at the end of the month.


Homburger provides Swiss law advice to IWG plc. The Homburger team is led by partner Daniel Hasler (Corporate | M&A) and comprises partners Reto Heuberger (Tax), Gregor Bühler (IP | IT) and Franz Hoffet (Competition | Regulatory), associates Guy Deillon, Angela Oppliger, Marc Hanslin (all Corporate | M&A), and Jan Seltmann (Tax), junior associate Gregor Schifferle (Corporate | M&A), and paralegal Maria Braun (Corporate | M&A).

Mehr lesen
2019-11-11

On October 25, 2019, Homburger's client entered into an investment and subscription agreement relating to shares in a company developing technology solutions for health measurement.

On October 25, 2019, Homburger's client entered into an investment and subscription agreement relating to shares in a company developing technology solutions for health measurement. The transaction was closed on November 1, 2019.


The Homburger team in this transaction was led by partner Daniel Hasler (Corporate | M&A) and included associates Karin Mattle (Corporate | M&A) and Katrina Frame (IP | IT) and junior associates Therry Lehmann and Gregor Schifferle (both Corporate | M&A).

Mehr lesen
2019-10-29

On September 3, 2019, Tiedemann Advisors, one of the largest independent U.S. investment and wealth advisors for high-net-worth families, trusts, foundations, and endowments, and Constantia Partners AG, an independent Swiss capital consultancy firm, announced that they agreed to establish Tiedemann Constantia.

On September 3, 2019, Tiedemann Advisors, one of the largest independent U.S. investment and wealth advisors for high-net-worth families, trusts, foundations, and endowments, and Constantia Partners AG, an independent Swiss capital consultancy firm, announced that they agreed to establish Tiedemann Constantia. Through this agreement, Tiedemann Constantia will offer a unique set of investment and wealth management services to high-net-worth individuals, families, family offices and foundations on multiple continents.


Homburger advised all parties to this transaction. The Homburger team was led by Andreas Müller (Corporate | M&A, Employment Law and Executive Compensation) and comprised associates Anna Peter and Aron Waltuch and paralegal Nora Mena (all Corporate | M&A), partner Benjamin Leisinger (Banking and Finance) and associate Luca Dal Molin (Technology and Digital Economy).

Mehr lesen
2019-10-22

On October 11, 2019, UBS Group AG was successfully substituted for UBS Group Funding (Switzerland) AG as issuer under all 34 outstanding additional tier 1 instruments and bail-in bonds (collectively, the Notes) issued by UBS Group Funding (Switzerland) AG and with an aggregate principal amount of approximately USD 40 bn.

On October 11, 2019, UBS Group AG was successfully substituted for UBS Group Funding (Switzerland) AG as issuer under all 34 outstanding additional tier 1 instruments and bail-in bonds (collectively, the Notes) issued by UBS Group Funding (Switzerland) AG and with an aggregate principal amount of approximately USD 40 bn. In connection with this issuer substitution, all rights and obligations of UBS Group Funding (Switzerland) AG under the Notes, as well as under the related internal loan agreements pursuant to which the net proceeds received from the issuance of the Notes were onlent to subsidiaries of UBS Group AG were transferred to UBS Group AG.


Homburger advised UBS with respect to all regulatory and transactional aspects of Swiss law. The Homburger team included partners Benedikt Maurenbrecher, Stefan Kramer (both Banking and Finance | Capital Markets) and Stefan Oesterhelt (Tax), as well as counsel Lee Saladino, associate Olivier Baum (both Banking and Finance | Capital Markets) and paralegal Ganna Goncharova (Banking and Finance).

Mehr lesen
2019-10-17

On September 11, 2019, Strides Pharma Science Limited (Strides), a global pharmaceutical company listed on the Bangalore Stock Exchange and National Stock Exchange of India Limited headquartered in Bangalore, India announced that it acquired a majority stake in Fairmed Healthcare AG (Fairmed), a Switzerland based company with a portfolio of high-quality generic products encompassing prescription and over-the-counter drugs across several therapeutic segments.

On September 11, 2019, Strides Pharma Science Limited (Strides), a global pharmaceutical company listed on the Bangalore Stock Exchange and National Stock Exchange of India Limited headquartered in Bangalore, India announced that it acquired a majority stake in Fairmed Healthcare AG (Fairmed), a Switzerland based company with a portfolio of high-quality generic products encompassing prescription and over-the-counter drugs across several therapeutic segments. Strides announced that its vast international product portfolio and Fairmed’s market access in the DACH region is a highly complementary combination to pivot an extensive growth in the coming years.


Homburger has advised Strides Pharma Science Limited in the transaction. The Homburger team was led by partners Frank Gerhard (Corporate | M&A) and Reto Heuberger (Tax) and included associates Laetitia Fracheboud (Tax), Christophe Chatelanat and Aron Waltuch (both Corporate | M&A) as well as junior associates Oriana Schöni and Nicolas Wetzel (both Corporate | M&A).

Mehr lesen
2019-10-15

On 15 October 2019, Amun AG (Amun), a Zug-based special purpose issuance vehicle of the fintech group Amun, successfully issued and listed a new series of USD-denominated Exchange Traded Products (ETPs) on the SIX Swiss Exchange.

On 15 October 2019, Amun AG (Amun), a Zug-based special purpose issuance vehicle of the fintech group Amun, successfully issued and listed a new series of USD-denominated Exchange Traded Products (ETPs) on the SIX Swiss Exchange. These products (Ticker: ABNB) are linked to the performance of BNB, the native token of the Binance Exchange, the largest crypto currency exchange in terms of trading volume globally, and one of the three largest utility tokens with multiple use cases. The products are fully collateralized by the underlying (BNB), which are stored with an independent custodian (Kingdom Trust). This series is the first ETP with an underlying crypto-asset that uses a Proof of Stake-based consensus mechanism wherein blocks are created by a group of pre-selected validators.


Homburger advised Amun with respect to all aspects of Swiss law. The Homburger team was led by partner Benjamin Leisinger (Capital Markets) and comprised associate Urs Meier and paralegal Ganna Goncharova (both Banking and Finance).

Mehr lesen